The OPTIMIZE Trial
- Study HIC#:2000032294
- Last Updated:05/18/2023
We invite you to take part in this research study because you have an inflammatory bowel disease, such as Crohn’s Disease (CD) or Ulcerative Colitis (UC) and your gastroenterologist is recommending that you start infliximab treatment as part of your medical care.
- Age18 years - 80 years
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Elizabeth Ruggiero
- Phone Number: 1-203-785-4576
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
We invite you to take part in this research study because you have an inflammatory bowel disease, such as Crohn’s Disease (CD) or Ulcerative Colitis (UC) and your gastroenterologist is recommending that you start infliximab treatment as part of your medical care.
Eligibility Criteria
Inclusion:
- Males or non-pregnant females aged 18-80.
- Diagnosed (by colonoscopy and/or imaging) with moderately to severely active IBD (Crohns disease or Ulcerative Colitis) and never treated with Inflximab
- Must be able to sign consent form and fully participate in all aspects of the tria
Principal Investigator
- Score: 1
